These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11989839)

  • 1. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
    Wang LS; Chow KC; Wu YC
    Scand J Gastroenterol; 2002 Apr; 37(4):467-75. PubMed ID: 11989839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 in human non-small cell lung cancer.
    Fang HY; Lin TS; Lin JP; Wu YC; Chow KC; Wang LS
    Eur J Surg Oncol; 2003 Mar; 29(2):171-7. PubMed ID: 12633561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.
    Vogt T; McClelland M; Jung B; Popova S; Bogenrieder T; Becker B; Rumpler G; Landthaler M; Stolz W
    Melanoma Res; 2001 Dec; 11(6):587-99. PubMed ID: 11725205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
    Noguchi K; Shitashige M; Ishikawa I
    J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
    Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
    Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas.
    Jiang JG; Tang JB; Chen CL; Liu BX; Fu XN; Zhu ZH; Qu W; Cianflone K; Waalkes MP; Wang DW
    World J Gastroenterol; 2004 Aug; 10(15):2168-73. PubMed ID: 15259059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.
    Ratnasinghe D; Tangrea J; Roth MJ; Dawsey S; Hu N; Anver M; Wang QH; Taylor PR
    Anticancer Res; 1999; 19(1A):171-4. PubMed ID: 10226539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma.
    Kuo KT; Chow KC; Wu YC; Lin CS; Wang HW; Li WY; Wang LS
    Ann Thorac Surg; 2003 Sep; 76(3):909-14. PubMed ID: 12963227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2.
    Blom MA; van Twillert MG; de Vries SC; Engels F; Finch CE; Veerhuis R; Eikelenboom P
    Brain Res; 1997 Nov; 777(1-2):210-8. PubMed ID: 9449430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID.
    Liu X; Li P; Zhang ST; You H; Jia JD; Yu ZL
    Dis Esophagus; 2008; 21(1):9-14. PubMed ID: 18197933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
    Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
    Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
    J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts.
    Tipton DA; Flynn JC; Stein SH; Dabbous MKh
    J Periodontol; 2003 Dec; 74(12):1754-63. PubMed ID: 14974816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.